Drug
CA-008
CA-008 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
100%(5 trials)
Phase Distribution
Ph phase_2
3
60%
Ph phase_1
2
40%
Phase Distribution
2
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
3(60.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 12 (40.0%)
Phase 23 (60.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_1
Study Evaluating the Safety, Efficacy and Pharmacokinetics of CA-008 (Vocacapsaicin)
NCT04203537
completedphase_2
Study of CA-008 (Vocacapsaicin) in Total Knee Arthroplasty
NCT03731364
completedphase_2
Open-Label CA-008 (Vocacapsaicin) in Bunionectomy
NCT03885596
completedphase_2
Study of CA-008 (Vocacapsaicin) in Bunionectomy Patients
NCT03599089
completedphase_1
A Phase 1 Study of Intraoperative Administration of CA-008 for the Correction of Hallux Valgus Deformity
NCT03307837
Clinical Trials (5)
Showing 5 of 5 trials
NCT04203537Phase 1
Study Evaluating the Safety, Efficacy and Pharmacokinetics of CA-008 (Vocacapsaicin)
NCT03731364Phase 2
Study of CA-008 (Vocacapsaicin) in Total Knee Arthroplasty
NCT03885596Phase 2
Open-Label CA-008 (Vocacapsaicin) in Bunionectomy
NCT03599089Phase 2
Study of CA-008 (Vocacapsaicin) in Bunionectomy Patients
NCT03307837Phase 1
A Phase 1 Study of Intraoperative Administration of CA-008 for the Correction of Hallux Valgus Deformity
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5